Coronary Microvascular Disease: Clinical Trials

2 trials for Coronary Microvascular Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Unknown 1
Phase 31Unknown 1

Follow Coronary Microvascular Disease: new trials by email Literature Review of Coronary Microvascular Disease trials Research Report on Coronary Microvascular Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
CLBS16, Placebo - Coronary Microvascular Dysfunction, Coronary Microvascular Disease
Phase 2TerminatedLisata Therapeutics, Inc.342020-10-292026-05-04
Rhodiola Rosea for Coronary Microvascular Disease
Rhodiola Rosea Capsules, Placebo - Coronary Microvascular Disease
Phase 2 / Phase 3UnknownQilu Hospital of Shandong University1142020-01-012020-01-06

Narrower conditions

Microvascular Angina (2)  ·  Angina Pectoris (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Vascular Diseases (2)  ·  Angina Pectoris (1)  ·  Chest Pain (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Lisata Therapeutics, Inc. (1)  ·  Qilu Hospital of Shandong University (1)

Countries

United States (1)

Top investigators

Kristen K Buck, MD (1)

Results publications

PMID 34066713